The effect of hypertonic sodium chloride hydroxyethyl starch 40 injection on neurocognitive disorders in patients undergoing shoulder arthroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026996

Enrollment

Unknown

Registered

2019-10-28

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder joint injury

Interventions

NS group:Normal saline infusion

HS group:HSH40 infusion

Eligibility

Sex/Gender

All

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. Aged 40-65 years.

Exclusion criteria

Exclusion criteria: 1. with a history of chronic pain, drug allergy, antidepressant use, liver and kidney dysfunction, electrolyte disorder, or autoimmune disease; 2. with a history of mental illness; 3. MMSE < 23.

Design outcomes

Primary

Measure	Time frame
TNF-a;	—

Countries

China

Contacts

Public ContactQiujun Wang

The Third Hospital of Hebei Medical University

13933178001@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026